Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration.

PURPOSE To examine the incidence of seed migration detected on chest X-ray and to identify the predictors associated with its occurrence. METHODS AND MATERIALS Between May 1998 and April 2000, 102 patients underwent permanent prostate brachytherapy at our institution and 100 were eligible for the study. Chest X-rays obtained at follow-up were examined for the number and location of seeds. The patient and treatment variables potentially associated with the occurrence and number of seed migrations were analyzed. RESULTS One or more seeds were identified on the chest X-rays of 55 (55%) of 100 patients. The mean number of intrathoracic seeds in patients with migration was 2.2 (range, 1-10), and the proportion of seeds that migrated to the thorax was 0.98%. The rate of extraprostatic seeds planned was 43.9%, and postimplant CT identified 37.9% in such a location. The number of seeds planned for extraprostatic placement and below the apex were statistically significant (alpha = 0.05) predictors in univariate logistic analysis. Multivariate analysis revealed the planned number of extraprostatic seeds as the only statistically significant predictor (p = 0.04). CONCLUSION Extraprostatic placement of loose seeds is associated with an increased likelihood for, and frequency of, seed migration to the thorax. Nonetheless, the small proportion of implanted seeds that migrated (<or=1%) is highly unlikely to have significant dosimetric consequences.

[1]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[2]  R. Stock,et al.  A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.

[3]  J M Collins,et al.  Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. , 1998, International journal of radiation oncology, biology, physics.

[4]  Toshio Ohashi,et al.  [Pulmonary embolization of permanently implanted radioactive iodine-125 seeds for carcinoma of the prostate]. , 2005, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[5]  P L Roberson,et al.  Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.

[6]  B. Davis,et al.  Prostate brachytherapy seed migration to a coronary artery found during angiography. , 2002, The Journal of urology.

[7]  S Huttner,et al.  [A rare route for the loss of a 125-iodine seed after the interstitial therapy of prostatic carcinoma]. , 1992, Der Urologe. Ausg. A.

[8]  D W Hillman,et al.  The radial distance of extraprostatic extension of prostate carcinoma , 1999, Cancer.

[9]  P L Roberson,et al.  Optimal placement of radioisotopes for permanent prostate implants. , 1996, Radiology.

[10]  Bernard Francis King,et al.  178 Supplemental implantation for suboptimal permanent prostate brachytherapy: A prostate phantom study , 2000 .

[11]  David Beyer,et al.  Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. , 2002, International journal of radiation oncology, biology, physics.

[12]  J J Prete,et al.  A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. , 1998, International journal of radiation oncology, biology, physics.

[13]  D. Bostwick,et al.  The radial distance of extraprostatic extension of prostatic adenocarcinoma: Implications for prostate brachytherapy , 1998 .

[14]  A. Steinfeld,et al.  Pulmonary embolization of iodine-125 seeds following prostate implantation. , 1991, Urology.

[15]  F M Waterman,et al.  Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. , 1996, International journal of radiation oncology, biology, physics.

[16]  P. Grimm,et al.  American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[17]  D. Bostwick,et al.  Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary? , 2000, Techniques in urology.

[18]  M Wannenmacher,et al.  Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.

[19]  S Nag,et al.  Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.

[20]  Dan Ash,et al.  Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  P. Walsh,et al.  An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. , 1979, The Journal of urology.

[22]  B. Davis,et al.  Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. , 2000, The Journal of urology.

[23]  P L Roberson,et al.  Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.

[24]  M Wannenmacher,et al.  [A rare complication of interstitial therapy with iodine-125 seeds: embolization of a seed into the lung]. , 1988, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[25]  S. Tong,et al.  Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. , 1998, Ultrasound in medicine & biology.

[26]  L. F. Fajardo.  Basic mechanisms and general morphology of radiation injury. , 1993, Seminars in roentgenology.

[27]  S Nag,et al.  The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. , 2000, International journal of radiation oncology, biology, physics.

[28]  S. Nag.  Principles and practice of brachytherapy , 1997 .

[29]  T. Krupski,et al.  Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. , 2001, The Journal of urology.

[30]  J J Prete,et al.  Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. , 1998, Radiology.

[31]  A. Dicker,et al.  Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry. , 2001, International journal of radiation oncology, biology, physics.

[32]  W. Butler,et al.  Seed fixity in the prostate/periprostatic region following brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[33]  C. Roehrborn,et al.  Interexaminer reliability of transrectal ultrasound for estimating prostate volume. , 2001, The Journal of urology.

[34]  T W Griffin,et al.  Reduction of radioactive seed embolization to the lung following prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[35]  B R Prestidge,et al.  Radioisotopic implantation for carcinoma of the prostate: does it work better than it used to? , 1998, Seminars in radiation oncology.

[36]  J. Blasko,et al.  Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma , 1997, Cancer.

[37]  P. Roberson,et al.  Source placement error for permanent implant of the prostate. , 1997, Medical physics.

[38]  H. Levin,et al.  Extent of extracapsular extension in localized prostate cancer. , 2000, Urology.